Our BioTalent Social community came together for an informative discussion on ‘The Next Generation of Cell & Gene Therapies,’ hosted by our very own James Hume. The discussion touched on a multitude of topical themes and insights, including: 

• The role of tech-transfer offices in turning early-stage interventions into products 
• Current challenges and opportunities for CGT start-ups in Europe  
• The complexities of clinical trials, and how we can make this smoother 
• PHDs: the importance of scientific and entrepreneurial learning 
• Viral vs. non-viral vectors 
• Mindset in CGT: the importance of resilience, perseverance and ambiguity tolerance 

Thank you to our wonderful panel members Stephen Sullivan, Kerstin Papenfuss and John Counsell for their sharp and focussed insights.